Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Article Title: Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice.
doi: 10.1016/j.ymthe.2024.05.003
Figure Lengend Snippet: Figure 3. RBD-specific TFH and B cell subsets induced upon single dose immunization with Clec9A-RBD (A) Experimental design schematic to characterize the antigen-specific humoral response elicited in 5- to 6-week-old BALB/c mice (n = 5 per group) s.c. immunized once with 2 mg Clec9A-RBD adjuvanted with 50 mg poly I:C. (B and C) Percentage of spleen RBD-specific (B) GC B cells (B220+ IgD GL-7+ CD95+ RBD++) and (C) MBC (B220+ IgD CD27+ RBD++) measured at 7 days and 1, 6, 9, and 12 months (circle = 6 months, triangle = 9 months, diamond = 12 months) after immunization were determined by flow cytometry. (D) Frequency of bone marrow ASC reactive to ancestral and variant SARS-CoV-2 RBD measured at 1, 6, 9, and 12 months (circle = 6 months, triangle = 9 months, diamond = 12 months), and 21 months after immunization were determined by B cell ELISPOT. Bone marrow cells from naive mice were assessed against ancestral SARS- CoV-2 RBD as a negative control. (E) Percentage of Activation-induced markers positive (AIM+) TFH cells CD3+ CD4+ CXCR5+ PD-1+ CD25+ CD69+) in response to re-stimulation with ancestral and variant SARS-CoV-2 RBD peptides in spleens at 7 days, and 6, 9, and 12 months (circle = 6 months, triangle = 9 months, diamond = 12 months) after immunization were determined by flow cytometry. Splenocytes from naive mice were restimulated with ancestral SARS-CoV-2 RBD peptides as a negative control. (B–E) Symbols represent individual animals and bars represent the mean. Statistical analysis: (B and C) Non-parametric two-tailed Mann-Whitney test or (D and E) Kruskal-Wallis test with Dunnett’s correction for multiple comparisons. *p < 0.05 or **p < 0.01.
Article Snippet: After 30 min incubation at RT, cells were washed twice with 1 Flow Cytometry Perm Buffer prepared as per the manufacturer’s instructions (TNB-0607-KIT; Tonbo Biosciences) before staining with intracellular marker antibodies for 1 h at 4 C in the dark (Table S2).
Techniques: Cytometry, Variant Assay, Enzyme-linked Immunospot, Negative Control, Activation Assay, Two Tailed Test, MANN-WHITNEY